The Lancet Countdown finds climate-related health risks accelerating, from heat deaths and shifting infections to worsening exposure, while Italy shows both progress and gaps.
For many problem drinkers, the after-work drink is automatic. Now, some patients of Sylvie Stacy, MD, tell her they pour a glass, take a sip or two, and walk away. Sylvie Stacy, MD “That sense of ...
In women with female pattern hair loss, low-dose oral minoxidil and 5% topical foam showed similar changes in Sinclair scores, but disease progression was less common with oral drug, a study found.
With GLP-1 receptor agonist (GLP-1 RAs) use on the rise in reproductive age women, the American College of Obstetricians and Gynecologists (ACOG) has released new guidance on a growing challenge in ...
AI chatbots may be fueling delusions and even triggering psychosis in people with no history of mental illness, in some of the first systematic clinical evidence linking chatbot interactions to ...
WASHINGTON — Children whose pediatricians recommended initiating the human papillomavirus (HPV) vaccination series at ages 9-10 had over twice the odds of starting and completing the series by age 13 ...
In the emergency room, AI outperformed two senior attendings. In the radiology lab, an AI platform increased the detection of steatotic liver by 360%. And just this month, women across the US gained ...
The HER2-targeted antibody-drug conjugate (ADC) trastuzumab rezetecan more than doubled progression-free survival compared with standard chemotherapy in patients with HER2-low advanced breast cancer ...
Research presented at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting in New Orleans examined how beauty products can harm the eyes, offered longer-term data on a system to improve ...
Read clinically focused news coverage of key developments from CEPAS 2026.
Can Yale legally require cognitive exams of older doctors at its New Haven hospital? That question appears headed for trial after a federal judge’s ruling in a long-running dispute between Yale and ...
NEW YORK — It is too early to determine whether the risk for hair shedding or thinning associated with GLP-1 receptor agonists (GLP-1 RAs) differs meaningfully by race or skin type because there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results